신규 다중치환 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 이상세포 성장 질환의 예방 및 치료용 약학적 조성물
    45.
    发明公开
    신규 다중치환 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 이상세포 성장 질환의 예방 및 치료용 약학적 조성물 有权
    取代多取代苯并噻唑或其药学上可接受的盐的新型吡啶衍生物,其制备方法和药物组合物,用于预防和治疗含有作为活性成分的异常细胞生长疾病

    公开(公告)号:KR1020120100845A

    公开(公告)日:2012-09-12

    申请号:KR1020120070944

    申请日:2012-06-29

    Abstract: PURPOSE: A pharmaceutical composition containing pyridine derivative subsituted with multiple substituted benzoxazole is provided to prevent and treat abnormal cell growth diseases. CONSTITUTION: A pyridine derivative substituted with multiple substituted benzoxazole is denoted by chemical formula 1. A method for preparing the derivative or pharmaceutically acceptable salt thereof comprises: a step of substituting a compound of chemical formula 2 to prepare a compound of chemical formula 4; a step of cyclizing the compound of chemical formula 4 to prepare a compound of chemical formula 5; a step of substituting the compound of chemical formula 5 to prepare a compound of chemical formula 6; a step of Suzuki coupling reaction of the compound of chemical formula 6 with a compound of chemical formula 7 to prepare a compound of chemical formula 8; a step of hydrogenation of the compound of chemical formula 8 to prepare a compound of chemical formula 9; a step of addition reaction of the compound of chemical formula 9 with a compound of chemical formula 10 to prepare a compound of chemical formula 11; and a step of deprotecting the compound of chemical formula 11.

    Abstract translation: 目的:提供含有由多取代苯并恶唑取代的吡啶衍生物的药物组合物,以预防和治疗异常的细胞生长疾病。 构成:用多取代的苯并恶唑取代的吡啶衍生物由化学式1表示。制备衍生物或其药学上可接受的盐的方法包括:用化学式2的化合物代替化学式4化合物的步骤; 使化学式4的化合物环化以制备化学式5的化合物的步骤; 用化学式5的化合物代替化学式6化合物的步骤; 化学式6的化合物与化学式7化合物的Suzuki偶联反应步骤,制备化学式8的化合物; 化学式8的化合物的氢化步骤,以制备化学式9的化合物; 化学式9的化合物与化学式10的化合物的加成反应步骤,制备化学式11的化合物; 以及使化学式11的化合物脱保护的工序。

    제초활성을 가지는 페닐이속사졸린계 화합물 및 이의 용도
    46.
    发明授权
    제초활성을 가지는 페닐이속사졸린계 화합물 및 이의 용도 有权
    具有除草活性的苯并恶唑化合物及其用途

    公开(公告)号:KR101093102B1

    公开(公告)日:2011-12-13

    申请号:KR1020110100842

    申请日:2011-10-04

    CPC classification number: A01N43/80 C07D261/04

    Abstract: PURPOSE: A phenylisoxazoline compound and a method for preparing the same are provided to ensure high herbicidal activity with safety and to improve productivity of crops. CONSTITUTION: An ortho-substituted phenylisoxazoline compounds containing 2,6-difluorobenzyloxymethyl is denoted by chemical formula 1. In chemical formula I, R1 is C1-C4 alkyl group, halogen group, or haloalkyl group; R2 is hydrogen, methyl group, or ethyl group. An herbicide contains phenylisoxazoline compounds of chemical formula 1, racemic body thereof, or mirror image isomer as an active ingredient.

    Abstract translation: 目的:提供苯基异恶唑啉化合物及其制备方法,以确保高度的除草活性,安全性和提高农作物的生产力。 构成:化学式1表示含有2,6-二氟苄氧基甲基的邻位取代苯基异恶唑啉化合物。化学式I中,R 1为C 1〜C 4烷基,卤素基或卤代烷基。 R2是氢,甲基或乙基。 除草剂含有化学式1的苯基异恶唑啉化合物,其外消旋体或镜像异构体作为活性成分。

    글리벤클라마이드의 제조방법
    49.
    发明授权
    글리벤클라마이드의 제조방법 失效
    글리벤클라마이드의제조방법

    公开(公告)号:KR100402055B1

    公开(公告)日:2003-10-17

    申请号:KR1020010022944

    申请日:2001-04-27

    Abstract: PURPOSE: Provided is a method for economically synthesizing glibenclamide, with powder shape, which is used as an intermediate for synthesis of medicine useful for treatment of diabetes. CONSTITUTION: The method comprises the steps of (i) reacting N-phenethyl-5-chloro-2-methoxybenzamide with chlorosulfonic acid(ClSO3H) represented by formula 2 in the presence of thionyl chloride(SOCl2) to form p-(N-phenethyl-5-chloro-2-methoxybenzamide)sulfonylchloride represented by formula 3; (ii) reacting sulfonylchloride compound represented by formula 3 with ammonia to form p-(N-phenethyl-5-chloro-2-methoxybenzamide)sulfoneamide represented by formula 4; (iii) reacting sulfoneamide compound represented by formula with alkali metal hydroxide in the presence of alcohol solvent to form p-(N-phenethyl-5-chloro-2-methoxybenzamide)sulfone amide-metal salt represented by formula 5; and (iv) reacting the metal represented by formula 5 with cyclohexyl isocyanate or phenylcyclohexyl carbamate to form glibenclamide represented by formula 1.

    Abstract translation: 目的:提供一种经济地合成格列本脲粉末状的方法,其用作合成用于治疗糖尿病的药物的中间体。 构成:该方法包括以下步骤:(i)使N-苯乙基-5-氯-2-甲氧基苯甲酰胺与式2代表的氯磺酸(ClSO 3 H)在亚硫酰氯(SOCl 2)存在下反应形成对 - (N-苯乙基 -5-氯-2-甲氧基苯甲酰胺)磺酰氯,由式3表示; (ii)使由式3表示的磺酰氯化合物与氨反应以形成由式4表示的对 - (N-苯乙基-5-氯-2-甲氧基苯甲酰胺)磺酰胺; (ⅲ)在醇溶剂存在下使下式表示的磺酰胺化合物与碱金属氢氧化物反应,生成式5表示的对 - (N-苯乙基-5-氯-2-甲氧基苯甲酰胺)磺酰胺 - 金属盐; (iv)使由式5表示的金属与环己基异氰酸酯或苯基环己基氨基甲酸酯反应以形成由式1表示的格列本脲。

    제초성 할옥시폽 아미드 화합물
    50.
    发明公开
    제초성 할옥시폽 아미드 화합물 无效
    除草抗坏血酸化合物

    公开(公告)号:KR1020010106604A

    公开(公告)日:2001-12-07

    申请号:KR1020000027433

    申请日:2000-05-22

    Abstract: 본 발명은 다음 화학식 1로 표시되는 할옥시폽 아미드 화합물과 그의 제조방법, 벼농사에서 발생하는 피를 방제하는 용도, 이들 화합물을 포함하는 제초제 조성물에 관한 것이다.

    상기 화학식 1에서 :
    R은 메틸기, 또는 에틸기를 나타내고; X는 수소원자, 할로겐원자, 시아노기, C
    1 ∼C
    6 의 알킬기, C
    1 ∼C
    6 의 알콕시기, 1∼3개의 할로겐원자가 치환된 C
    1 ∼C
    3 의 할로알킬기, 1∼3개의 할로겐원자가 치환된 C
    1 ∼C
    3 의 할로알콕시기, C
    2 ∼C
    4 의 알콕시알콕시기, C
    2 ∼C
    6 의 알케닐기, 또는 C
    2 ∼C
    6 의 알케닐옥시기를 나타내고; Y는 수소원자, 또는 플루오로원자를 나타내고; n은 1, 또는 2의 정수를 나타내며, n이 2일 경우 X는 각기 다른 치환체들의 조합이 되어도 좋다.

Patent Agency Ranking